Acute Myleoid Leukemia
Acute myeloid leukemia (AML) has many other names, including acute myelocytic leukemia, acute myelogenous leukemia, acute granulocytic leukemia, and acute non-lymphocytic leukemia. “Acute” means that this leukemia can progress quickly if not treated, and would probably be fatal in a few months. “Myeloid” refers to the type of cell this leukemia starts from. Most cases of AML develop from cells that would turn into white blood cells (other than lymphocytes), but some cases of AML develop in other types of blood-forming cells.
AML starts in the bone marrow (the soft inner part of certain bones, where new blood cells are made), but in most cases it quickly moves into the blood. It can sometimes spread to other parts of the body including the lymph nodes, liver, spleen, central nervous system (brain and spinal cord), and testicles. It occurs in both adults and children and affects about 18,000 people each year in the U.S.
Related Journals of Acute Myleoid Leukemia
Journal of Leukemia, Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Oncology & Cancer Case Reports, Clinical Lymphoma, Myeloma and Leukemia, Hematological Oncology, International Journal of Clinical Oncology, Acta Oncologica, Cancer Control, Seminars in Oncology
High Impact List of Articles